Mobile Health to Promote Physical Activity Post Stroke

Stroke Clinical Trial

— ENAbLE-Swe  

Official title:

ENAbLE-Sweden. Secondary Prevention of Stroke: Mobile Health to Promote Physical Activity in People Post Stroke or Transient Ischemic Attack

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05111951
• Other study ID #: Dnr 2020-05062
• Secondary ID: 2022-014032021-0
• Status: Completed
• Phase: N/A
• Start date: November 1, 2021
• Est. completion date: December 22, 2023

Study information

• Verified date: December 2023
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Support for physical activity is necessary to sustain health and reduce the risk of stroke recurrence after stroke or transient ischemic attack (TIA). Still, rehabilitation services are not available to many of those who potentially would benefit from such services largely due to barriers related to accessibility. While mobile health is a promising strategy to support physical activity, there is a gap in knowledge regarding the implementation of technology that meet the needs of people post stroke or TIA in order to foster adherence and engagement in physical activity. This project therefore seeks to improve health and reduce the risk of recurrent stroke among people post stroke or TIA by increasing the access to physical activity through telehealth. The present project builds on experiences of telehealth-delivered physical activity in Australia where restricted access to health-care services is a longstanding problem. Collaborating researchers in Australia have developed a telehealth program (i-REBOUND- Let's get moving) which has been designed and tested in collaboration with end users, through a series of feasibility and pilot studies. The i-REBOUND program provides support for physical activity through physical exercises supervised by a physiotherapist and behavior change techniques for physical activity (i.e. individual counseling, information, recommendations, goal-setting, self-monitoring and structured follow-ups) across 6 months. The intervention is delivered to people post stroke or TIA in their own homes via video-meeting. This study, which is conducted in Sweden, aims to evaluate if the i-REBOUND program supported by a new mobile application could be delivered as intended through a pilot randomized controlled trial in order to determine the feasibility and preliminary effects in people post stroke or TIA living in urban and rural regions of Sweden.

Description:

In order to make the i-REBOUND program accessible to people post stroke or TIA across Sweden, a mobile application was developed in a co-design process with people post stroke or TIA, physiotherapists and stakeholders. The application enables monitoring and management of exercise (supervised online and prescribed exercise), communication through video calls and chat, self-monitoring of exercise compliance and physical activity, and scheduled digital surveys on function and health. The application will be used in this study to deliver the experimental and control intervention, but also for remote assessments of function and health (e.g. digital questionnaires). Study participants will be randomized to 1) an experimental group (n=60) receiving the mobile health version of the i-REBOUND program or 2) a control group (n=60) receiving behavioural change techniques for physical activity. The randomization schedule; 1:1, will be blocked and stratified by mobility status (independent/mobility device users) and geographical region (urban/rural areas). Recruitment: Participants will be recruited through a national network of clinical sites across Sweden, social media and patient organizations. Screening: Potential participants will be contacted via phone and verbal consent will be sought to provide further information. During this phone conversation, trial eligibility will be assessed according to the inclusion/exclusion criteria using a standardized checklist, including questions regarding cognitive functioning and the individual's usage of mobile applications. Sample size: The anticipated sample size of 60 participants per group (total 120) builds on the ambition to test the feasibility of the i-REBOUND program among people post stroke/TIA with variation in disability, age and sex, and geographical location within Sweden (i.e. cities and rural areas). Analysis: Outcomes of feasibility and safety (see primary outcomes) will primarily be analyzed using descriptive statistics in order to explore if the digital version of the i-REBOUND program could be delivered as intended. Preliminary effects of the intervention (see secondary outcomes) will be analyzed using a mixed-model analysis (or equivalent non-parametric statistics if the data is not normally distributed) to target differences in changes between the groups (experimental vs control) and time (baseline, and the 3, 6 and 12-months follow-up) on clinical outcomes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 116
• Est. completion date: December 22, 2023
• Est. primary completion date: December 22, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Aged over 18 years
• Diagnosed with stroke/TIA between 3 months to 10 years prior to study enrollment
• Living at home
• Have sufficient cognitive ability and/or support from family member in order to engage in the interventions
• Being able to walk short distances indoors
• Ability to use a smartphone/tablet including access to stable internet connection.

Exclusion Criteria:

• Medical conditions limiting the ability to exercise (e.g. unstable cardiac conditions or severe arthritis)
• Severe neglect and aphasia compromising the ability to follow instructions
• Meeting the recommended physical activity levels of at least 150 min per week of moderate physical activity or at least 75 min per week of vigorous intensity physical activity
• Enrolled in another physical activity trial.

Related Conditions & MeSH terms

• Ischemic Attack, Transient
• Stroke
• Transient Ischemic Attack

Intervention

Behavioral:
• Mobile health-delivered physical exercise and support for physical activity
Mobile health-delivered physical exercise sessions, prescription of an individual exercise-regime and support for physical activity through behavior change techniques.
• Mobile health-delivered behavior change techniques.
Mobile health-delivered behavior change techniques following the core elements of the Swedish model for physical activity on prescription.

Locations

Country	Name	City	State
Sweden	Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society Karolinska Institutet	Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

References & Publications (2)

English C, Attia JR, Bernhardt J, Bonevski B, Burke M, Galloway M, Hankey GJ, Janssen H, Kuys S, Lindley RI, Lynch E, Marsden DL, Nilsson M, Ramage ER, Said CM, Spratt NJ, Zacharia K, Macdonald-Wicks L, Patterson A. Secondary Prevention of Stroke: Study Protocol for a Telehealth-Delivered Physical Activity and Diet Pilot Randomized Trial (ENAbLE-Pilot). Cerebrovasc Dis. 2021;50(5):605-611. doi: 10.1159/000515689. Epub 2021 Apr 23. — View Citation

Thurston C, Bezuidenhout L, Humphries S, Johansson S, von Koch L, Hager CK, Holmlund L, Sundberg CJ, Garcia-Ptacek S, Kwak L, Nilsson M, English C, Conradsson DM. Mobile health to promote physical activity in people post stroke or transient ischemic attack - study protocol for a feasibility randomised controlled trial. BMC Neurol. 2023 Mar 28;23(1):124. doi: 10.1186/s12883-023-03163-0. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Recruitment rate	The proportion of participants screened who will be deemed eligible for the trial and the proportion of those consented who will be randomized to the trial.	Throughout the intervention period (0-6 months)
Primary	Sample representativeness	Contrasting the demographic details of study sample with national data.	Throughout the intervention period (0-6 months)
Primary	Compliance to the clinical trial	Number of participants who will not complete the trial.	Throughout the intervention period (0-6 months)
Primary	Compliance to the intervention protocol	Number of intervention sessions not completed and the reason for uncompleted sessions.	Throughout the intervention period (0-6 months)
Primary	Fidelity - exercise dose	Performed exercise dose (i.e. number of sessions).	Throughout the intervention period (0-6 months)
Primary	Fidelity - physical intensity	Performed exercise intensity assessed using the Borg Rating of Perceived Exertion Scale. The Borg Rating of Perceived Exertion Scale assess perceived exertion based on a 6 to 20 rating scale (higher score = higher perceived exertion).	Throughout the intervention period (0-6 months)
Primary	Fidelity - individual physical activity counseling	Performance of individual physical activity counseling.	Throughout the intervention period (0-6 months)
Primary	Fidelity - information on physical activity and health	Provision of information on physical activity and health.	Throughout the intervention period (0-6 months)
Primary	Fidelity - individual physical activity goals	Establishment of individual physical activity goals.	Throughout the intervention period (0-6 months)
Primary	Fidelity - structured follow-ups of goal fulfillment	Performance of structured follow-ups of goal fulfillment.	Throughout the intervention period (0-6 months)
Primary	Compliance to treatment protocols	Adherence to treatment schedules.	Throughout the intervention period (0-6 months)
Primary	Compliance to the assessment protocols	Adherence to assessment schedules.	Throughout the intervention period (0-6 months)
Primary	Adverse events	Adverse events may include falls, injuries, gastrointestinal issues requiring medical review or cardiac events. Trial therapists will record any adverse events that occur during telehealth sessions, and participants will answer a study specific questionnaire at the commencement of each exercise session, and at each assessment to self-report any adverse events that occur at other times during the study.	Throughout the study period (0-12 months)
Secondary	Systolic blood pressure	Systolic blood pressure measured with a portable blood pressure monitor (Omron M7 Intelli IT-AFIB), to be measured 3 times in the morning and afternoon for 7 days consecutively (minimum 3 days or 6 measures required to be used in the project evaluation).	3 months, 6 months, and 12 months after baseline assessment
Secondary	Physical activity - walking time	Walking time (minutes) per day as measured by the ActivPal accelerometer to be worn continuously for 7 consecutive days (minimum of 3 days data required to be used in the evaluation)	3 months, 6 months, and 12 months after baseline assessment
Secondary	Physical activity - number of daily steps	Number of daily steps as measured by the ActivPal accelerometer to be worn continuously for 7 consecutive days (minimum of 3 days data required to be used in the evaluation)	3 months, 6 months, and 12 months after baseline assessment
Secondary	Physical activity - standing time	Standing time (minutes) per day as measured by the ActivPal accelerometer to be worn continuously for 7 consecutive days (minimum of 3 days data required to be used in the evaluation)	3 months, 6 months, and 12 months after baseline assessment
Secondary	Sedentary - sitting time	Sitting time (minutes) per day as measured by the ActivPal accelerometer to be worn continuously for 7 consecutive days (minimum of 3 days data required to be used in the evaluation)	3 months, 6 months, and 12 months after baseline assessment
Secondary	Walking abilities	Generic Walk-12 Scale: - 12 item scores summed to a total score with a possible range between 0 and 42 (higher score = more walking difficulties).	3 months, 6 months, and 12 months after baseline assessment
Secondary	Confidence performing daily activities	Activities-Specific Balance Confidence scale; - 16 item scores averaged to a mean score with a possible range between 0 to 100 (higher score = higher balance confidence).	3 months, 6 months, and 12 months after baseline assessment
Secondary	Self-efficacy for exercise	Exercise Self-Efficacy Scale; - 9 item scores averaged to a mean score with a possible range between 0 to 100 (higher score = highly confident to exercise).	3 months, 6 months, and 12 months after baseline assessment
Secondary	Fatigue	Fatigue Severity Scale; - 9 item scores summed to a total score with a possible range between 9 and 63 (higher score = greater fatigue severity).	3 months, 6 months, and 12 months after baseline assessment
Secondary	Depression, anxiety and stress	Depression Anxiety Stress Scale (DASS-21); - DASS-21 contains 21 questions divided in 3 subscales (depression, anxiety and stress) with 7 items on each scale. Each sub-scale is summed into a total score with a possible range between 0 and 24 (higher score = higher levels of symptoms related to depression/anxiety/stress).	3 months, 6 months, and 12 months after baseline assessment
Secondary	Health-related Quality of life	EuroQuol-5 Dimensions (EQ5D); EQ5D comprises: 5-items survey (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), resulting in a 5-digit summary index which describes the patient's health state.; Assessment of the person's self-rated health on a vertical visual analogue scale (VAS), where the endpoints are labelled 'The best health you can imagine' and 'The worst health you can imagine'. The VAS scale (ranging between 0 to 100, higher value = better self-rated health).	6 months, and 12 months after baseline assessment